Intravenous and extraamniotic administration of prostaglandin F2 alpha and control of electrocardiogram, blood pressure and pulse rate.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to H U Lau.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
In a case-control-study an epidemiological investigation of cancer of the endometrium was carried out. 407 patients with cancer of the endometrium were compared with a control group of 450 women. The patients with endometrial cancer differed from the control group in the following manner: Significantly higher incidence of diabetes mellitus and hypertension. Overweight could not be printed out reliably, but there are so many corresponding statements in literature about a higher degree of overweight that there could be no doubt about it. Furthermore the patients with carcinoma of the uterine corpus had an earlier menarche, a later menopause, a smaller number of deliveries and more menstrual abnormalities. They were more exposed to radiation in the pelvis, the incidence of malignant tumors was higher in their families. So factors of high risk related to cancer of the endometrium could be defined.
A report of intraamniotic application of prostaglandin F2alpha in 40 cases is given. There were 13 primiparous and 27 multiparous women. In 97,5% (39 cases) the artificial abortion or the opening of the cervical channel, which is necessary for the evacuation of the uterus, could be achieved. The average dose of prostaglandin F2alpha was 28,8 mg, the mean time for induction was 16 hours 14 minutes. The intraamniotic application of prostaglandin can be applied successfully for abortion in the second three months' time.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.